IBDEI04N ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1899,1,5,0)
 ;;=5^PSYCHOLOGICAL STRESS
 ;;^UTILITY(U,$J,358.3,1899,2)
 ;;=^87822
 ;;^UTILITY(U,$J,358.3,1900,0)
 ;;=V62.9^^18^177^36
 ;;^UTILITY(U,$J,358.3,1900,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1900,1,2,0)
 ;;=2^V62.9
 ;;^UTILITY(U,$J,358.3,1900,1,5,0)
 ;;=5^PSYCHOSOCIAL CIRCUM NOS
 ;;^UTILITY(U,$J,358.3,1900,2)
 ;;=^295551
 ;;^UTILITY(U,$J,358.3,1901,0)
 ;;=V62.89^^18^177^38
 ;;^UTILITY(U,$J,358.3,1901,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1901,1,2,0)
 ;;=2^V62.89
 ;;^UTILITY(U,$J,358.3,1901,1,5,0)
 ;;=5^RELIGIOUS PROBLEMS
 ;;^UTILITY(U,$J,358.3,1901,2)
 ;;=^303725
 ;;^UTILITY(U,$J,358.3,1902,0)
 ;;=V61.9^^18^177^37
 ;;^UTILITY(U,$J,358.3,1902,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1902,1,2,0)
 ;;=2^V61.9
 ;;^UTILITY(U,$J,358.3,1902,1,5,0)
 ;;=5^RELATIONAL PROBLEM
 ;;^UTILITY(U,$J,358.3,1902,2)
 ;;=^303721
 ;;^UTILITY(U,$J,358.3,1903,0)
 ;;=V65.42^^18^177^39
 ;;^UTILITY(U,$J,358.3,1903,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1903,1,2,0)
 ;;=2^V65.42
 ;;^UTILITY(U,$J,358.3,1903,1,5,0)
 ;;=5^SUBSTANCE ABUSE COUNSELING
 ;;^UTILITY(U,$J,358.3,1903,2)
 ;;=^303467
 ;;^UTILITY(U,$J,358.3,1904,0)
 ;;=V62.0^^18^177^40
 ;;^UTILITY(U,$J,358.3,1904,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1904,1,2,0)
 ;;=2^V62.0
 ;;^UTILITY(U,$J,358.3,1904,1,5,0)
 ;;=5^UNEMPLOYMENT
 ;;^UTILITY(U,$J,358.3,1904,2)
 ;;=^123545
 ;;^UTILITY(U,$J,358.3,1905,0)
 ;;=V65.49^^18^177^30
 ;;^UTILITY(U,$J,358.3,1905,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1905,1,2,0)
 ;;=2^V65.49
 ;;^UTILITY(U,$J,358.3,1905,1,5,0)
 ;;=5^OTHER SPECIFIED COUNSELING
 ;;^UTILITY(U,$J,358.3,1905,2)
 ;;=^303471
 ;;^UTILITY(U,$J,358.3,1906,0)
 ;;=V58.61^^18^177^17
 ;;^UTILITY(U,$J,358.3,1906,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1906,1,2,0)
 ;;=2^V58.61
 ;;^UTILITY(U,$J,358.3,1906,1,5,0)
 ;;=5^L/T (CURRENT) USE - ANTICOAG
 ;;^UTILITY(U,$J,358.3,1906,2)
 ;;=^303459
 ;;^UTILITY(U,$J,358.3,1907,0)
 ;;=V58.62^^18^177^19
 ;;^UTILITY(U,$J,358.3,1907,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1907,1,2,0)
 ;;=2^V58.62
 ;;^UTILITY(U,$J,358.3,1907,1,5,0)
 ;;=5^L/T (CURRENT) USE ANTIBIOTIC
 ;;^UTILITY(U,$J,358.3,1907,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,1908,0)
 ;;=V58.63^^18^177^21
 ;;^UTILITY(U,$J,358.3,1908,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1908,1,2,0)
 ;;=2^V58.63
 ;;^UTILITY(U,$J,358.3,1908,1,5,0)
 ;;=5^LNG USE ANTIPLTE/THRMBTC
 ;;^UTILITY(U,$J,358.3,1908,2)
 ;;=^329978
 ;;^UTILITY(U,$J,358.3,1909,0)
 ;;=V58.64^^18^177^22
 ;;^UTILITY(U,$J,358.3,1909,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1909,1,2,0)
 ;;=2^V58.64
 ;;^UTILITY(U,$J,358.3,1909,1,5,0)
 ;;=5^LONG-TERM ANTI-INFLAMTRY
 ;;^UTILITY(U,$J,358.3,1909,2)
 ;;=^329979
 ;;^UTILITY(U,$J,358.3,1910,0)
 ;;=V58.65^^18^177^25
 ;;^UTILITY(U,$J,358.3,1910,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1910,1,2,0)
 ;;=2^V58.65
 ;;^UTILITY(U,$J,358.3,1910,1,5,0)
 ;;=5^LONG-TERM USE STEROIDS
 ;;^UTILITY(U,$J,358.3,1910,2)
 ;;=^329980
 ;;^UTILITY(U,$J,358.3,1911,0)
 ;;=V58.66^^18^177^23
 ;;^UTILITY(U,$J,358.3,1911,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1911,1,2,0)
 ;;=2^V58.66
 ;;^UTILITY(U,$J,358.3,1911,1,5,0)
 ;;=5^LONG-TERM USE OF ASPIRIN
 ;;^UTILITY(U,$J,358.3,1911,2)
 ;;=^331584
 ;;^UTILITY(U,$J,358.3,1912,0)
 ;;=V58.67^^18^177^24
 ;;^UTILITY(U,$J,358.3,1912,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1912,1,2,0)
 ;;=2^V58.67
 ;;^UTILITY(U,$J,358.3,1912,1,5,0)
 ;;=5^LONG-TERM USE OF INSULIN
 ;;^UTILITY(U,$J,358.3,1912,2)
 ;;=^331585
 ;;^UTILITY(U,$J,358.3,1913,0)
 ;;=V58.69^^18^177^18
 ;;^UTILITY(U,$J,358.3,1913,1,0)
 ;;=^358.31IA^5^2
